Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolated Pelvic and Limb Girdle Perfusion with TNFa in Sarcoma
NCT00181025Phase 2Unknown
- Sponsor
- Gustave Roussy
- Start
- May 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tasonermin in soft tissue sarcoma (STS) and bone sarcoma, sponsored by Gustave Roussy. Primary endpoint: Complete response rate on MRI. Status: unknown.
02
Drugs
tasonermin
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT00181025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181025.